http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006528211-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-80 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate | 2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006528211-A |
| titleOfInvention | Medicine for internal use for cancer treatment |
| abstract | An object of the present invention is to provide a low-cost anti-cancer internal medicine that enables the most effective attack against cancer tumors, has few side effects. The composition comprises a polydimethylsiloxane and a surfactant, and the fraction of polydimethylsiloxane exceeds the fraction of surfactant, and constitutes an anti-cancer drug for internal use. The fraction of the mixture of the two constituents is in the range of about 90 to 99.9% polydimethylsiloxane, preferably 99% by weight, and 0.1 to 10% surfactant, preferably 1% by weight. It is. |
| priorityDate | 2003-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.